[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Mena et al., 2020 - Google Patents

A droplet-based microfluidic viscometer for the measurement of blood coagulation

Mena et al., 2020

View HTML
Document ID
6451846321103479439
Author
Mena S
Li Y
McCormick J
McCracken B
Colmenero C
Ward K
Burns M
Publication year
Publication venue
Biomicrofluidics

External Links

Snippet

A continuous microfluidic viscometer is used to measure blood coagulation. The viscometer operates by flowing oil and blood into a cross section where droplets are generated. At a set pressure, the length of the droplets is inversely proportional to the viscosity of the blood …
Continue reading at www.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/49Blood
    • G01N33/4905Determining clotting time of blood
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N11/00Investigating flow properties of materials, e.g. viscosity, plasticity; Analysing materials by determining flow properties
    • G01N11/02Investigating flow properties of materials, e.g. viscosity, plasticity; Analysing materials by determining flow properties by measuring flow of the material

Similar Documents

Publication Publication Date Title
Mena et al. A droplet-based microfluidic viscometer for the measurement of blood coagulation
Karon Why is everyone so excited about thromboelastrography (TEG)?
US9562914B2 (en) Microfluidic device for real-time clinical monitoring and quantitative assessment of whole blood coagulation
JP4725819B2 (en) System, method and computer-implemented process for analyzing coagulation of a fluid sample
Lehmann et al. On-chip recalcification of citrated whole blood using a microfluidic herringbone mixer
Selby “TEG talk”: expanding clinical roles for thromboelastography and rotational thromboelastometry
Prisco et al. Point-of-care testing of hemostasis in cardiac surgery
JP2016503161A (en) Centrifugal force microfluidic platelet complex function and drug reaction test apparatus and method
BR112017004506B1 (en) ASSAY MICROCHIP FOR MEASUREMENT OF COAGULATION IN A BLOOD OR PLASMA SAMPLE, MICROASSAY DEVICE FOR MEASUREMENT OF COAGULATION IN A BLOOD OR PLASMA SAMPLE FROM AN INDIVIDUAL AND METHOD FOR MEASUREMENT OF COAGULATION TIME
JP7070641B2 (en) Platelet agglutination ability analyzer, platelet agglutination ability analysis system, platelet agglutination ability analysis program and platelet agglutination ability analysis method
Guler et al. Self-powered disposable prothrombin time measurement device with an integrated effervescent pump
Chen et al. Point-of-care blood coagulation assay based on dynamic monitoring of blood viscosity using droplet microfluidics
Hyatt et al. Point of care assessment of coagulation
WO2018128002A1 (en) Blood-coagulation-system analyzer, blood-coagulation-system analysis system, blood-coagulation-system analysis method, blood-coagulation-system analysis program, hemorrhage-volume predictor, hemorrhage-volume prediction system, hemorrhage-volume prediction method, and hemorrhage-volume prediction program
Rossi et al. Scalable manufacture of a disposable, storage-stable eight-channel microfluidic device for rapid testing of platelet, coagulation, and drug function under whole blood flow
Holt et al. Quasi‐static acoustic tweezing thromboelastometry
US11998911B2 (en) Microfluidic thromboelastometry instrument
Yu et al. Real-time measurement of thrombin generation using continuous droplet microfluidics
Silverberg et al. Comparison of citrated and fresh whole blood for viscoelastic coagulation testing during elective neurosurgery
MacIvor et al. 27 How do we integrate thromboelastography with perioperative transfusion management? _3728 1386.. 1392
Shiraishi et al. Hemolysis and von Willebrand factor degradation in mechanical shuttle shear flow tester
Lin et al. Comparing a piezoelectric quartz crystal with an optical coagulometer in monitoring high-dose heparin therapy by determining whole blood activated partial thromboplastin time and activated clotting time
Kang Simultaneous measurement method of erythrocyte sedimentation rate and erythrocyte deformability in resource-limited settings
US20210354135A1 (en) Systems and methods for evaluating an ability of a blood sample to coagulate, clot, and/or occlude
JP6750443B2 (en) Platelet aggregation analysis method, platelet aggregation analysis device, platelet aggregation analysis program, and platelet aggregation analysis system